Use of botulinum toxin in cheiloplasty: A new method to decrease tension

Iván Marcelo Cueva Galárraga1

  • 1Plastic Surgery Service, Club de Leones Quito Central, Central Médico Comunitario, Quito, Pichincha, Ecuador.

Insights

Botulinum toxin injections during cheiloplasty significantly reduced upper lip tension in infants with cleft lip and palate. Electromyography confirmed decreased orbicularis oris muscle activity, aiding surgical wound healing.

Area of Science:

  • Plastic Surgery
  • Pediatric Surgery
  • Neuromuscular Medicine

Background:

  • Cleft lip and palate repair (cheiloplasty) can be complicated by muscle tension at the surgical site.
  • Managing this tension is crucial for optimal wound healing and aesthetic outcomes in infants.

Purpose of the Study:

  • To evaluate the efficacy of botulinum toxin in reducing surgical wound tension during cheiloplasty.
  • To assess the impact of botulinum toxin on orbicularis oris muscle activity in infants undergoing cleft lip repair.

Main Methods:

  • A prospective study involving five infants under six months with complete cleft lip and palate.
  • Electromyography (EMG) was performed before and 10 days after cheiloplasty with botulinum toxin (10 units) injection into the upper lip.
  • Millard-type cheiloplasty was the surgical technique employed.

Main Results:

  • A statistically significant change (P<0.039) in EMG readings was observed post-botulinum toxin application.
  • The reduction in muscle activity was particularly notable during periods of rest.
  • Botulinum toxin effectively inhibited the orbicularis oris muscle's action.

Conclusions:

  • Botulinum toxin administration during cheiloplasty effectively reduces tension at the surgical wound level.
  • Electromyographic evidence supports the role of botulinum toxin in inhibiting the orbicularis oris muscle, especially at rest.
  • This intervention shows promise for improving outcomes in cleft lip and palate repair by managing muscle-related wound tension.
Abstract

Related Concept Videos

Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...